Related Experiment Videos

The epidermal growth factor receptor as a novel target for cancer therapy: case studies and clinical implications

Jeanne Riddle1, Pamela Lee, Michelle Purdom

  • 1University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd, Box 432, Houston, TX 77030, USA.

Abstract

Insights

Targeted therapies for epidermal growth factor receptor, including monoclonal antibodies and tyrosine kinase inhibitors, show promise for non-small cell lung cancer and other malignancies with limited toxicity.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Review of therapies targeting the epidermal growth factor receptor (EGFR).
  • Focus on agents like IMC-C225, ZD1839, and OSI-774.

Observation:

  • Ongoing research indicates promise for EGFR-targeted therapies.
  • These include monoclonal antibodies and small-molecule tyrosine kinase inhibitors.

Findings:

  • EGFR-targeted therapies demonstrate efficacy as single agents or in combination with chemotherapy/radiation.
  • These novel treatments exhibit limited host toxicity.

Implications:

  • Nurses play a crucial role in administering EGFR-targeted therapies and managing toxicities.
  • Coordination of treatment protocols and ensuring patient compliance are key nursing responsibilities.

Related Concept Videos